Follow
Raoul Herbrecht
Raoul Herbrecht
Institut de Cancérologie Strasbourg.Europe, Hôpitaux Universitaires, INSERM U1113 Strasbourg, France
Verified email at icans.eu - Homepage
Title
Cited by
Cited by
Year
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma
B Coiffier, E Lepage, J Brière, R Herbrecht, H Tilly, R Bouabdallah, ...
New England Journal of Medicine 346 (4), 235-242, 2002
66872002
Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National …
B De Pauw, TJ Walsh, JP Donnelly, DA Stevens, JE Edwards, T Calandra, ...
Clinical Infectious Diseases 46 (12), 1813-21, 2008
5920*2008
Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis
R Herbrecht, DW Denning, TF Patterson, JE Bennett, RE Greene, ...
New England Journal of Medicine 347 (6), 408-415, 2002
4133*2002
Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America
TJ Walsh, EJ Anaissie, DW Denning, R Herbrecht, DP Kontoyiannis, ...
Clinical Infectious Diseases 46 (3), 327-360, 2008
35892008
Practice guidelines for the diagnosis and management of aspergillosis: 2016 update by the Infectious Diseases Society of America
TF Patterson, GR Thompson III, DW Denning, JA Fishman, S Hadley, ...
Clinical Infectious Diseases 63 (4), e1-e60, 2016
27602016
ESCMID guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients
OA Cornely, M Bassetti, T Calandra, J Garbino, BJ Kullberg, O Lortholary, ...
Clinical Microbiology and Infection 18, 19-37, 2012
13222012
Diagnosis and management of Aspergillus diseases: Executive summary of the 2017 ESCMID-ECMM-ERS guideline
AJ Ullmann, JM Aguado, S Arikan-Akdagli, DW Denning, AH Groll, ...
Clinical Microbiology and Infection 24 (Suppl 1), e1-e38, 2018
12622018
International conference for the development of a consensus on the management and prevention of severe candidal infections
JE Edwards, GP Bodey, RA Bowden, T Büchner, BE de Pauw, SG Filler, ...
Clinical Infectious Diseases 25 (1), 43-59, 1997
1114*1997
Efficacy and safety of voriconazole in the treatment of acute invasive aspergillosis
DW Denning, P Ribaud, N Milpied, D Caillot, R Herbrecht, E Thiel, A Haas, ...
Clinical Infectious Diseases 34 (5), 563-571, 2002
11012002
Treatment of invasive aspergillosis with posaconazole in patients who are refractory to or intolerant of conventional therapy: An externally controlled trial
TJ Walsh, I Raad, TF Patterson, P Chandrasekar, GR Donowitz, R Graybill, ...
Clinical Infectious Diseases 44 (1), 2-12, 2007
8922007
Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): a phase 3, randomised-controlled …
JA Maertens, II Raad, KA Marr, TF Patterson, DP Kontoyiannis, ...
The Lancet 387 (10020), 760-769, 2016
8642016
Liposomal amphotericin B as initial therapy for invasive mold infection: a randomized trial comparing a high–loading dose regimen with standard dosing (AmBiLoad trial)
OA Cornely, J Maertens, M Bresnik, R Ebrahimi, AJ Ullmann, E Bouza, ...
Clinical Infectious Diseases 44 (10), 1289-1297, 2007
8332007
Phase III study to evaluate temsirolimus compared with investigator's choice therapy for the treatment of relapsed or refractory mantle cell lymphoma
G Hess, R Herbrecht, J Romaguera, G Verhoef, M Crump, C Gisselbrecht, ...
Journal of Clinical Oncology 27 (23), 3822-3829, 2009
7502009
Candidemia in cancer patients: A prospective, multicenter surveillance study by the Invasive Fungal Infection Group (IFIG) of the European Organization for Research and …
C Viscoli, C Girmenia, A Marinus, L Collette, P Martino, B Vandercam, ...
Clinical Infectious Diseases 28 (5), 1071-1079, 1999
7441999
Imaging findings in acute invasive pulmonary aspergillosis: clinical significance of the halo sign
RE Greene, HT Schlamm, JW Oestmann, P Stark, C Durand, O Lortholary, ...
Clinical Infectious Diseases 44 (3), 373-379, 2007
7382007
Posaconazole as salvage therapy for zygomycosis
RN Greenberg, K Mullane, JAH Van Burik, I Raad, MJ Abzug, G Anstead, ...
Antimicrobial agents and chemotherapy 50 (1), 126-133, 2006
6672006
Isavuconazole treatment for mucormycosis: a single-arm open-label trial and case-control analysis
FM Marty, L Ostrosky-Zeichner, OA Cornely, KM Mullane, JR Perfect, ...
The Lancet Infectious Diseases 16 (7), 828-837, 2016
6622016
ECIL-6 guidelines for the treatment of invasive candidiasis, aspergillosis and mucormycosis in leukemia and hematopoietic stem cell transplant patients
F Tissot, S Agrawal, L Pagano, G Petrikkos, AH Groll, A Skiada, ...
Haematologica, 2016.152900, 2016
6582016
European guidelines for antifungal management in leukemia and hematopoietic stem cell transplant recipients: summary of the ECIL 3 - 2009 update
J Maertens, O Marchetti, R Herbrecht, OA Cornely, U Flückiger, P Frere, ...
Bone Marrow Transplantation 46 (5), 709-718, 2011
6022011
Phase III randomized study of bendamustine compared with chlorambucil in previously untreated patients with chronic lymphocytic leukemia
WU Knauf, T Lissichkov, A Aldaoud, A Liberati, J Loscertales, R Herbrecht, ...
Journal of Clinical Oncology 27 (26), 4378-4384, 2009
5992009
The system can't perform the operation now. Try again later.
Articles 1–20